Improved gas exchange and survival after KL-4 surfactant in newborn pigs with severe acute lung injury

Pediatric Pulmonology

Volumn 45, Issue 8, 2010, Pages 782-788

  Zimmermann, Anna M ^a,b   Roberts, Kari D ^a,b   Lampland, Andrea L ^a,b   Meyers, Patricia A ^b   Worwa, Cathy T ^b   Plumm, Brenda ^b   Cristina Pacheco, M ^b   Wolfson, Marla R ^c   Mammel, Mark C ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute lung injury; Animal model; Surfactant therapy; Synthetic surfactant

Indexed keywords

HYDROCHLORIC ACID; LUCINACTANT;

ACIDOSIS; ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL GAS; ARTERIAL OXYGEN TENSION; ARTERIAL PH; ARTICLE; ATELECTASIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; EXTUBATION; HISTOPATHOLOGY; LUNG GAS EXCHANGE; NEWBORN; NONHUMAN; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SURVIVAL;

ACIDOSIS, RESPIRATORY; ACUTE LUNG INJURY; ANIMALS; ANIMALS, NEWBORN; BLOOD GAS ANALYSIS; DISEASE MODELS, ANIMAL; PEPTIDES; POSITIVE-PRESSURE RESPIRATION; PULMONARY ATELECTASIS; PULMONARY GAS EXCHANGE; SEVERITY OF ILLNESS INDEX; SWINE;

EID: 77956119800     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21252     Document Type: Article

References (27)

1. Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 1959;97:517-523.
2. Gregory TJ, Longmore WJ, Moxley MA, Whitsett JA, Reed CR, Fowler AA 3rd, Hudson LD, Maunder RJ, Crim C, Hyers TM. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991;88:1976-1981.
3. Veldhuizen RAW, McCaig LA, Akino T, Lewis JF. Pulmonary surfactant subfractions in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1995;152:1867-1871.
4. Hallman M, Spragg R, Harrell JH, Moser KM, Gluck L. Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J Clin Invest 1982;70:673.
5. Anzueto A, Baughman RP, Kalpalatha KG, et al. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N Engl J Med 1996;334:1417-1421.
6. Gregory TJ, Steinberg KP, Spragg R, et al. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997;155:1309-1315.
7. Spragg RG, Lewis JF, Walmrath HD, et al. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 2004;351:884-892.
8. Davidson WJ, Dorscheid D, Spragg R, et al. Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis. Crit Care 2006;10:R41. (Pubitemid 47086801)
9. Keseciojlu J, Haitsma JJ. Surfactant therapy in adults with acute lung injury/acute respiratory distress syndrome. Curr Opin Crit Care 2006;12:55-60.
10. Willson DF, Thomas NJ, Markovitz BP, et al. Effect of exogenous surfactant (calfactant) in pediatric acute lung injury. J Am Med Assoc 2005;293:470-476.
11. Whitsett JA, Ohning BL, Ross G, et al. Hydrophobic surfactant associated protein in whole lung surfactant and its importance for biophysical activity in lung surfactant extracts used in replacement therapy. Pediatr Res 1986;20:460-467.
12. Whitsett JA, Weaver TE. Hydrophobic surfactant proteins in lung function and disease. N Engl J Med 2002;347:2141-2148. (Pubitemid 36015127)
13. Cochrane CG, Revak SD. Pulmonary surfactant protein B (SP-B): structure-function relationships. Science 1991;254:566-568.
14. Rairkar M, Nutt M, Johnson ME. Robustness of exogenous lung surfactant to oxidative inactivation - a comparison of beractant (Survanta), calfactant (Infasurf), poractant (Curosurf), and lucinactant (Surfaxin). Pediatr Res 2006;59: PAS2006: 4840.142.
15. Merritt TA, et al. Reduction of the surface-tension-lowering ability of surfactant after exposure to hypochlorous acid. Biochem J 1993;295:19-22.
16. Andersson S, Kheiter A, Merritt TA. Oxidative inactivation of surfactants. Lung 1999;177:179-189.
17. Kinniry P, Pick J, Stephens S, et al. KL4-surfactant prevents hyperoxic and LPS-induced lung injury in mice. Pediatr Pulmonol 2006;41:916-928. (Pubitemid 44534809)
18. Zhu Y, Miller TL, Chidekel A, Shaffer TH. KL-4 surfactant (Lucinactant) protects human airway epithelium from hypoxia. Pediatr Res 2008;64:154-158.
19. Gastlasoro-Cuesta E, Alvarez-Diaz F, Rey-Santano C. Acute and sustained effects of lucinactant versus poractant-alpha on pulmonary gas exchange and mechanics in premature lambs with respiratory distress syndrome. Pediatrics 2006;117:295-303.
20. Sood SL, Balaraman V, Finn KC, Britton B, Uyehara FT, Easa D. Exogenous surfactants in a piglet model of acute respiratory distress syndrome. Am J Respir Crit Care Med 1996;153:820-828. (Pubitemid 26053280)
21. Sinha SK, Lacaze-Masmonteil T, Valls A, et al. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Pediatrics 2005;115:1030-1038.
22. Moya F, Gadzinowski J, Bancalari E, et al. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome in very preterm infants. Pediatrics 2005;115:1018-1029.
23. National Institutes of Health. Institute of Laboratory Animal Resources: guidelines for the care and use of laboratory animals (NIH 86-23). Bethesda, MD: National Institutes of Health; 2002.
24. Smith KM, Mrozek JD, Simonton SC, et al. Prolonged partial liquid ventilation using conventional and high frequency ventilatory techniques: gas exchange and lung pathology in an animal model of respiratory distress syndrome. Crit Care Med 1997;25:1888-1897.
25. Nawab US, Touch SM, Irwin-Sherman T, et al. Heliox attenuated lung inflammation and structural alterations in acute lung injury. Pediatr Pulmonol 2005;40:524-532.
26. Sweet CG, Halliday HL. The use of surfactants in 2009. Arch Dis Child Educ Pract 2009;94:78-83.
27. Willson D. Calfactant. Expert Opin Pharmacother 2001;2:1479-1493.